184 related articles for article (PubMed ID: 22532249)
1. Aloe-emodin suppresses prostate cancer by targeting the mTOR complex 2.
Liu K; Park C; Li S; Lee KW; Liu H; He L; Soung NK; Ahn JS; Bode AM; Dong Z; Kim BY; Dong Z
Carcinogenesis; 2012 Jul; 33(7):1406-11. PubMed ID: 22532249
[TBL] [Abstract][Full Text] [Related]
2. Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3-kinase-mediated Akt signaling.
Liu K; Park C; Chen H; Hwang J; Thimmegowda NR; Bae EY; Lee KW; Kim HG; Liu H; Soung NK; Peng C; Jang JH; Kim KE; Ahn JS; Bode AM; Dong Z; Kim BY; Dong Z
Mol Carcinog; 2015 Sep; 54(9):751-60. PubMed ID: 24700667
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the Scaffolding Function of mLST8 Selectively Inhibits mTORC2 Assembly and Function and Suppresses mTORC2-Dependent Tumor Growth
Hwang Y; Kim LC; Song W; Edwards DN; Cook RS; Chen J
Cancer Res; 2019 Jul; 79(13):3178-3184. PubMed ID: 31085701
[TBL] [Abstract][Full Text] [Related]
4. Remarkable inhibition of mTOR signaling by the combination of rapamycin and 1,4-phenylenebis(methylene)selenocyanate in human prostate cancer cells.
Facompre ND; Sinha I; El-Bayoumy K; Pinto JT; Sinha R
Int J Cancer; 2012 Nov; 131(9):2134-42. PubMed ID: 22307455
[TBL] [Abstract][Full Text] [Related]
5. mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.
Guertin DA; Stevens DM; Saitoh M; Kinkel S; Crosby K; Sheen JH; Mullholland DJ; Magnuson MA; Wu H; Sabatini DM
Cancer Cell; 2009 Feb; 15(2):148-59. PubMed ID: 19185849
[TBL] [Abstract][Full Text] [Related]
6. Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival.
Wang Y; Mikhailova M; Bose S; Pan CX; deVere White RW; Ghosh PM
Oncogene; 2008 Nov; 27(56):7106-17. PubMed ID: 18776922
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of androgen receptor signaling by aloe-emodin.
Zhao J; Sun Y; Ren L; Huang S; Zhang J
Food Chem Toxicol; 2023 Nov; 181():114092. PubMed ID: 37806336
[TBL] [Abstract][Full Text] [Related]
8. Aloe emodin suppresses EGF‑induced neoplastic cell transformation by inhibiting the ERK/MSK1 and AKT/GSK3β signaling pathways.
Zhang J; Guo L; Zhang Q; Liu K; Dong Z
Mol Med Rep; 2018 Dec; 18(6):5215-5220. PubMed ID: 30272294
[TBL] [Abstract][Full Text] [Related]
9. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH
J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906
[TBL] [Abstract][Full Text] [Related]
10. The functions of mTOR in ischemic diseases.
Hwang SK; Kim HH
BMB Rep; 2011 Aug; 44(8):506-11. PubMed ID: 21871173
[TBL] [Abstract][Full Text] [Related]
11. Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin.
Zou Z; Chen J; Yang J; Bai X
Curr Cancer Drug Targets; 2016; 16(4):288-304. PubMed ID: 26563881
[TBL] [Abstract][Full Text] [Related]
12. mLST8 Promotes mTOR-Mediated Tumor Progression.
Kakumoto K; Ikeda J; Okada M; Morii E; Oneyama C
PLoS One; 2015; 10(4):e0119015. PubMed ID: 25906254
[TBL] [Abstract][Full Text] [Related]
13. Aloe-Emodin Ameliorates Renal Fibrosis Via Inhibiting PI3K/Akt/mTOR Signaling Pathway
Dou F; Liu Y; Liu L; Wang J; Sun T; Mu F; Guo Q; Guo C; Jia N; Liu W; Ding Y; Wen A
Rejuvenation Res; 2019 Jun; 22(3):218-229. PubMed ID: 30215298
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2.
Luo Y; Liu L; Wu Y; Singh K; Su B; Zhang N; Liu X; Shen Y; Huang S
Oncotarget; 2015 Feb; 6(6):4286-98. PubMed ID: 25738366
[TBL] [Abstract][Full Text] [Related]
15. Identification of rictor as a novel substrate of Polo-like kinase 1.
Shao T; Liu X
Cell Cycle; 2015; 14(5):755-60. PubMed ID: 25714006
[TBL] [Abstract][Full Text] [Related]
16. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1.
Guertin DA; Stevens DM; Thoreen CC; Burds AA; Kalaany NY; Moffat J; Brown M; Fitzgerald KJ; Sabatini DM
Dev Cell; 2006 Dec; 11(6):859-71. PubMed ID: 17141160
[TBL] [Abstract][Full Text] [Related]
17. Aloe-emodin inhibits HER-2 expression through the downregulation of Y-box binding protein-1 in HER-2-overexpressing human breast cancer cells.
Ma JW; Hung CM; Lin YC; Ho CT; Kao JY; Way TD
Oncotarget; 2016 Sep; 7(37):58915-58930. PubMed ID: 27391337
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic Therapy Mediated by Aloe-Emodin Inhibited Angiogenesis and Cell Metastasis Through Activating MAPK Signaling Pathway on HUVECs.
Chen Q; Li KT; Tian S; Yu TH; Yu LH; Lin HD; Bai DQ
Technol Cancer Res Treat; 2018 Jan; 17():1533033818785512. PubMed ID: 30068242
[TBL] [Abstract][Full Text] [Related]
19. Aloe-Emodin Isolated from
He MT; Nguyen QN; Cho EJ; Kim SH; Park S; Park JY; Lee S; Kang KS
J Diet Suppl; 2024; 21(3):389-407. PubMed ID: 38062982
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W.
Jeon YH; Park YH; Kwon JH; Lee JH; Kim IY
Biochim Biophys Acta; 2013 Oct; 1833(10):2135-42. PubMed ID: 23680186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
